Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dorzolamide-timolol combination

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with dorzolamide-timolol combination in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(dorzolamide-timolol combination)		Trials
(dorzolamide-timolol combination)		Recent Studies (post-2010) (dorzolamide-timolol combination)
9,156187552863653

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chatziralli, IP; Demopoulos, CA; Moschos, MM; Papakonstantinou, VD; Stamatakis, G; Tsatsos, M1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dorzolamide-timolol combination

ArticleYear
In Vitro Effects of Anti-Glaucomatous Eye Drops on Platelet-Activating Factor and its Metabolism.
    Seminars in ophthalmology, 2017, Volume: 32, Issue:2

    Topics: Animals; Disease Models, Animal; Drug Combinations; Glaucoma; Intraocular Pressure; Ophthalmic Solutions; Platelet Activating Factor; Platelet Aggregation; Rabbits; Sulfonamides; Thiophenes; Timolol

2017